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Effect of iron on acute pyelonephritis and later chronic changes.
Administration of iron to rats exacerbated early inflammatory changes
of pyelonephritis produced by intravenous inoculation of Escherichia
coli. This effect was noted with four of eight strains of E. coli tested and
was dependent on bacterial inodulum. Despite this increase in severity
of acute pyelonephritis as judged by numbers of bacteria in the kidney
and careful gross and microscopic evaluation, there was no enhance-
ment of chronic changes seen 6 months later.
Effet du fer sur Ia pyélonéphrite aigue et les modifications tardives
chroniques. L'administration de fer a des rats a exacerbé les modifica-
tions inflammatoires précoces de pyelonephrite produites par inocitla-
tion intraveineuse d'Escherichi coli. Cet effet a été observe pour quatre
des huit souches de E. coli utilisées et était dépendant de l'inoculation
bactérienne. Malgré cette augmentation de sévérité de Ia pyélonéphrite
aiguë jugée par le nombre de bactéries presentes dans le rein et une
étude macroscopique et microscopique soigneuse, ii n'y avait pas
d'augmentation des modifications chroniques vues 6 mois plus tard.
The effect of excess -iron on increasing and the depletion of
iron on decreasing severity of infection has been well docu-
mented. The subject was thoroughly reviewed by Weinberg [1]
who covered in vitro studies as well as data from experimental
and clinical infections. Additionally, he discussed the possible
mechanisms involved.
Two studies relative to experimental pyelonephritis have
been reported. Fletcher and Goldstein [21 found that injection of
small molecular weight iron complexes exacerbated three mod-
els of acute experimental hematogenous pyelonephritis: Esche-
richia coli and Staphylococcus albus in the rat, and Mycobacte-
riumfortuitum in the mouse. Henderson, Kadis, and Chapman
[3] found exacerbation of acute ascending Corynebacteriunt
renale pyelonephritis in the rat by similar iron injections.
In addition to these studies showing that iron exacerbates
pyelonephritis, Kochan, Kvach, and Wiles [41 demonstrated an
effect on mortality in mice injected with E. coli. If a microbial
strain of lower virulence was suspended in iron solution and
then injected into mice, the mortality in 2 days was increased
from 6 of 27 to 13 of 16. With a strain of higher virulence no
such effect was noted.
The current study was designed to determine whether or not
the increase in severity of E. coli pyelonephritis reported by
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Fletcher and Goldstein [21 for a period of 6 days could be
confirmed. It was further intended to determine whether or not
the effect would continue for a longer period. In addition, we
intended to test the hypothesis of Glauser, Lyons, and Braude
[5] that early suppuration is critical and related quantitatively to
eventual development of chronic pyelonephritis.
Methods
Animals. Fischer inbred female rats were obtained from
Charles River Farm (Cambridge, Massachusetts).
Bacteria and cultivation. Escherichia coil strains P92, 136,
and P98 were obtained from Dr. K. L. Vosti; CFI and 113 from
Dr. A. Braude; and serotype 027:B8 from Dr. M. Landy.
Strains 214 and Yale are laboratory strains originally isolated
from urine of patients with urinary tract infection.
Trypticase soy broth and agar (BBL, Cockeysville, Mary-
land) were used throughout the study. For animal passage to
enhance virulence, cultivation was on 5% sheep cell blood agar
plates (blood agar base, BBL).
Production of pyelonephritis. To maximize virulence, all
bacteria were animal passed as follows: The rat left ureter was
ligated and 0.5 ml of a thrice-washed suspension of an 18-hr
broth culture was injected intravenously. The following day,
the left kidney was removed, homogenized, streaked on a blood
agar plate and incubated at 37° C overnight. Several colonies
were reinoculated in broth, and the procedure was repeated
twice more. Colonies from the third animal passage were grown
in broth for 18 hr, frozen and stored at —20° C. Just prior to use,
one further animal passage was done. Several colonies were
placed in broth and incubated overnight at 37° C for intravenous
injection into rats without ureteral ligation.
At sacrifice, kidneys were removed and were graded for
gross abscesses and scars on a 0 to 4 scale of increasing severity
[6]. For some studies, a coronal section of each kidney was
placed in formalin for histologic examination. Sections were
stained with hematoxylin and eosin. The kidney sections were
randomized, coded, and read using a slight modification of our
previously described method [5]. A section of each kidney was
evaluated on a semiquantitative scale of 0 to 4+: (1) cortical
lesions (for example, edema, tubular atrophy, tubular basement
thickening, scars); (2) cortical mononuclear cell infiltrate; (3)
papillary lesions (for example, edema, hemorrhage, sclerosis);
(4) subcalyceal mononuclear infiltrate; and (5) calyceal epitheli-
al hyperplasia were each evaluated separately. A total score
indicative of overall severity of parenchymal lesions was deter-
mined by adding each of the individual scores (maximum 20). In
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Table 1. Effect of iron on acute hematogenous pyelonephritis due to E. coli P92 in the rat
Duration of
infection
Weeks Parameter Irons No iron
Statistical
ana1ysisL
Log no. bacterialg kidney
25 Kidneys
5.57 0.56 30 Kidneys2.90 0.31 P < 0.001
Proportion kidneys infected 22/26 23/30 NS
1 Abscesses
Proportion
Intensity score
17/26
1.80 0.30
2/30
0.07 0.05
P < 0.0005
P < 0.001
Scars
Proportion
Intensity score
0/26
—
0/30
—
Log no. bacteria/g kidney
24 Kidneys
2.92 0.5
30 Kidneys
0.84 0.29 P < 0.001
Proportion kidneys infected 15/24 7/30 P < 0.01
3 Abscesses
Proportion
Intensity score
12/24
0.79 0.19
1/30
0.03 0.03
P < 0.0005
P < 0.001
Scars
Proportion
Intensity score
3/24
0.20 0.13
4/30
0.13 0.06
NS
NS
10 mg/kg/rat from day —7 to +21.
b Student t test or x2.
Mean SEM.
addition, prevalence of intratubular leukocytes casts and corti-
cal or papillary abscess formation was determined. The signifi-
cance of differences in mean scores and prevalence of lesions
was determined by Student t test for unpaired data or x2
respectively. The remainder of each kidney was weighed and
homogenized; the bacterial content was determined by serial
dilution and pour plate count.
Iron treatment. Iron sorbitex, (Jectofer, Astra Pharmaceuti-
cal Products, Worcestershire, Massachusetts) was given once a
day intramuscularly. Details of duration of iron treatment are
given for individual experiments.
Results
Preliminary studies were done with eight strains of E. coli in
order to choose one strain and an inoculum level for further,
more extensive study. In this experiment, iron treatment was
begun the day of infection and continued daily for 1 week at
which time animals were sacrificed, gross kidney lesions were
noted, and numbers of bacteria in the kidney were determined.
The results indicated that the virulence of strains 214, P92, P98,
and CFI was enhanced by iron as judged by kidney bacterial
concentration and frequency of lesions. Strains Yale, 113,
027:B8, and 136 did not respond to iron administration. Second-
ly, with strains P92 and P98, as little as a two-fold drop in
bacterial concentration of the inoculum markedly reduced the
animal's response and eliminated the effect of iron. Parentheti-
cally, it should be noted that with two strains of Proteus
mirabilis and one of Pseudomonas aeruginosa no enhancing
effect of iron treatment on severity of hemotogenous pyelone-
phritis was found (data not shown).
On the basis of the preliminary results, strain P92 was chosen
for further evaluation of the effect of iron on acute pyelonephri-
tis. This strain, obtained from Dr. K. L. Vosti, is serotype 0:75.
It has been used previously in a study to correlate parasite
virulence in acute ascending E. coli pyelonephritis in mice
undergoing diuresis [7]. In this study, nephropathogenicity was
found to be correlated with the presence of K antigen, resist-
ance to phagocytosis and serum bactericidal activity, ability to
ferment dulcitol, and ability to multiply in urine and minimal
media. By these criteria P92 was quite virulent; it was third
among 22 strains studied. One hundred rats were used in this
study. Fifty were treated with daily iron starting 7 days before
infection (—7) and continued for 21 days postinfection (+21).
The infecting dose was 2.38 X 10 bacteria in 1 ml. Sacrifice of
iron-treated and untreated rats was at I and 3 weeks. Twenty-
five of 50 iron-treated rats and 20 of 50 untreated rats died,
mostly during the first week. The results are shown in Table 1.
In this table, subsequent tables, and Figure 1, numbers always
refer to kidneys, not animals. At 1 week, the proportion of
infected kidneys was not increased in iron-treated animals
because almost all kidneys in both groups were infected.
However, the bacterial content, incidence, and intensity of
abscesses were increased significantly. No scars were noted. At
3 weeks, bacterial content, proportion of infected kidneys, and
incidence and intensity of abscesses were all increased signifi-
cantly in the group receiving iron. Only a few scars were noted
in either group of animals without a difference in frequency or
intensity between iron groups and those without iron.
Furthermore, it is evident that the exacerbation of pyelone-
phritis induced by iron treatment clearly noted at 1 week was
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Fig. 1. Effect of iron on renal bacterial concentration and incidence of
infection in hematogenous Escherichia coli P92 pyelonephritis in the
rat. Vertical lines are mean SEM. Numbers at each time interval are
the proportion of kidneys with any bacteria over number tested. A
single asterisk indicates significant difference in bacterial concentration
in kidneys between iron-treated and untreated rats at a level of P < 0.05
or better (t test). Double asterisks indicate a significant difference in the
proportion of infected kidneys between iron-treated and untreated rats
at a level of P < 0.05 or better (x2).
beginning to decline by 3 weeks. This decline was apparent in
numbers of bacteria in the kidney and abscesses which, while
still significantly greater in iron treated than untreated rats,
were less in absolute numbers than at 1 week. Gross scars were
just beginning to appear at 3 weeks, but there was no difference
in the two groups of animals.
To further delineate the question as to whether or not the
exacerbation of pyelonephritis by iron is prolonged, a more
extensive experiment of 6 months' duration was designed. This
study was planned to answer the question as to whether or not a
more severe acute pyelonephritis, particularly with abscesses,
leads to a more severe residual chronic pyelonephritis.
Accordingly, 200 rats were treated with iron from day —7
prior to infection with P92 to day + 21. An equal number was
reserved as infected non-iron controls. Mortality was about
40% in both groups and mostly in the first week. In this study,
histologic examination was made. Ten iron-treated and ten
untreated rats were sacrificed at 1, 3, 8, 12, 16, and 24 weeks.
The microbiologic data are shown in Figure 1. The bacterial
content of the kidneys of iron-treated rats was significantly
higher than untreated animals up to 12 weeks but not subse-
quently. The incidence of infection was 100% at 1 week.
Subsequently, incidence of infection gradually declined in both
groups. By 12 weeks, the difference in proportion of infected
kidneys, while still higher in iron-treated animals (14/20 vs.
7/20), was no longer significant (P < 0.10). At 16 and 24 weeks
the incidence of infection was very small, and there was no
difference between the two groups. Table 2 shows incidence
and frequency of gross abscesses and scars. Gross abscesses
were significantly more frequent in iron-treated than untreated
animals at 1 week (19/20 vs. 2/20) and 3 weeks (17/20 vs. 2/20)
but not thereafter. Only at 12 weeks were scars significantly
more frequent in iron-treated animals (18/20 vs. 10/20). The
severity of gross abscesses was significantly greater in iron-
treated animals at 1 and 3 weeks but not later when both had
declined substantially. Scars began to appear at 3 weeks and
were significantly more severe in iron-treated rats at 8, 12, and
16 weeks but not 24 weeks.
The incidence of histologic changes was greater in iron-
treated than untreated animals at 1 week (19/20 vs. 8/20), 3
weeks (18/20 vs. 9/20), 8 weeks (20/20 vs. 13/20), and 16 weeks
(17/20 vs. 9/20). It was not significantly different at 12 weeks
(17/20 vs. 15/20), nor at 20 weeks (13/20 vs. 12/20). As shown in
Table 3, iron-treated animals had more severe pyelonephritis at
1, 3, and 8 weeks. At 12 weeks there was no statistically
significant difference nor at 24 weeks. However, at 16 weeks a
greater severity in iron-treated animals was noted. Examination
of the data indicated that these findings were not based on any
one of the parameters alone. The statistical outcome was due to
the combination of findings which in iron-treated animals was
greater at 16 weeks than at either 12 or 24 weeks while it was
lower in untreated animals. Because of the importance of the
finding at 24 weeks that no significant difference was present,
the slides for 24 weeks, as well as for 16 weeks, were rerando-
mized and again read blindly. The correlation for the two
readings averaged 0.825 leading to the same conclusion. The
failure to find a difference in overall severity of pyelonephritis
was not a consequence of further intensification of one parame-
ter with simultaneous reduction in the intensity of another
parameter.
Early other inflammatory lesions, that is, leucocyte tubular
casts and cortical or medullary abscesses, were not evaluated
as to severity, but their incidence is shown in Table 4. There
was a significantly greater incidence of casts at 1 and 3 weeks
and of abscesses at 1 week.
An additional finding common to all iron-treated groups was a
granular intracytoplasmic brownish pigment in tubular cells and
interstitial mononuclear cells in the cortex. Such cytoplasmic
pigment was more intense at the periphery of cortical scars
where it appeared to be associated with large mononuclear
cells. No pathologic lesions or pigment were observed in a
series of 25 normal rats injected with iron and sacrificed 1 to 16
weeks later.
Discussion
This study's principal finding of bacteriologic, gross, and
microscopic changes in E. coli infection in iron-treated and
control rats is the marked intensification of the early acute
inflammatory lesions in association with iron therapy. This
finding is associated with significantly enhanced bacterial multi-
plication in the renal parenchyma.
The exacerbation of acute pyelonephritis was not due to an
effect of the iron sorbitol complex on the reticuloendothelial
system. Similar results were obtained with soluble ferric ammo-
nium citrate by others [1, 21. We also have noted the same effect
with ferric ammonium citrate (unpublished observations). How-
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Table 2. Effect of iron on incidence and severity of gross abscesses and scars in hematogenous E. coli P92 pyelonephritis in the rat
Duration of
infection
weeks
Abscessesa Scarsa
Iron No ironIron' No iron
1 2.15 0.31h
(19/20)
0.10 0.07C
(2/20)
Øb
(0/20)
0
(0/20)
3 1.50 0.27
(18/20)
0.05 0.05c
(2/20)
0.10 0.07
(2/20)
0.05 0.05
(1/20)
8 0.25 0.14
(3/20)
0
(0/20)
1.45 0.18
(18/20)
0.80 0.09C
(16/20)
12 0.25 0.18
(2/20)
0
(0/20)
1.25 0.20
(18/20)
0.55 0.14c
(10/20)'
16 0.10 0.10
(1/20)
0
(0/20)
1.15 0.25
(14/20)
0.40 0.1l
(8/20)
24 0
(0/20)
0
(0/20)
0.90 0.18
(14/20)
0.50 0.11
(10/20)
Increasing severity 0 to 4; mean SEM; N = 20.
10 mg/kg/day, day —7 through day +21 of infection.
Significantly different, iron vs. no iron; x2 for incidence and I test for severity.
Figures in parentheses indicate proportion of kidneys with abscesses or scars of 20 kidneys examined.
Table 3. Effect of iron on severity of histologic lesions in
hematogenous E. co/i P92 pyelonephritis in the rat
Duration of
infection
weeks
Severity scorea
Significance'Ironb No iron
1 15.30 1.32" 2.40 1.14 P < 0.001
3 12.00 1.56 2.25 0.01 P < 0.001
8 12.78 1.34 4.90 1.17 P < 0.001
12 4.35 1.09 3.28 0.61 NS
16 5.80 1.22 1.40 0.44 P < 0.001
24 2.83 1.02 2.05 0.70 NS
a Five parameters of pyelonephritis were each graded on a 0 to 4
scale; cortical lesions, cortical mononuclear infiltrate, papillary lesions,
subcalyceal mononuclear infiltrate, and calyceal hyperplasia. The maxi-
mum possible score is 20. N = 20, same kidneys as described grossly in
Table 2.
10 mg/kg/day from day —7 through day +21 of infection.
Student's t test.
Mean SEM.
ever, despite the severe early lesion, the long-term course of the
gross and microscopic lesions and bacteriologic outcome were
not modified greatly by iron therapy. The prevalence and
severity of cortical and papillary chronic inflammatory and
scarring residue were not enhanced pan passu with the augmen-
tation of the early inflammatory lesion. These findings are not
entirely similar to those of Glauser, Lyons, and Braude [5] who
concluded, on the basis of studies with acute retrograde E. coii
pyelonephritis, that the intensity of the acute inflammation was
the major determinant of chronic scarring seen in this model.
Their studies involved unilateral pyelonephritis induced in the
male Wistar-Lewis rat by means of bladder inoculation with E.
coil 06 followed by 20 hr of ureteric obstruction produced by a
ureteral ligature. Microscopic evaluation was not performed
systematically. The degree of acute and chronic pyelonephritis
resulting from the experimental manipulation was assessed
using a ratio of kidney weights of the affected to the unaffected
side. A relative increase in weight on the affected side was used
Table 4. Effect of iron on incidence of polymorphonuclear leucocytes,
tubular casts, and cortical or medullary microscopic abscesses
Duration of
infection
weeks
Casts
Irona No iron Iron
Abscesses
No iron
I 14/20b 3/20 9/20" 1/20
3 11/20" 3/20 5/20 0/20
8 11/20 5/20 0/20 0/20
12 4/20 2/20 0/20 0/20
16 3/20 0/20 0/20 0/20
24 0/20 0/20 0/20 0/20
a 10 mg/kg/day —7 through day +21 of infection.
Significantly different iron vs. no iron (x2); N = 20.
as an index of the severity of acute suppuration, and a relative
decrease of kidney weight on the affected side was used as
evidence for chronic pyelonephritis. Early antimicrobial thera-
py (28 hr to 3 days after infection) greatly blunted or prevented
the chronic pyelonephritis changes seen 75 to 90 days later as
well as significantly ameliorating the manifestation of acute
suppuration. Delayed treatment with antimicrobial agents (that
is, 5 or 12 days after infection) had no effect on chronic changes
despite eradication of parenchymal infection. Partial treatment
at 28 to 30 hr of infection greatly reduced the extent of acute
suppuration and chronic pyelonephritis but did not greatly
influence the degree of persistent parenchymal infection which
was comparable to untreated controls.
There are several possible reasons for the difference in
eventual outcome between our study and that of Glauser,
Lyons, and Braude [5]. It may be simply a matter of the
duration of the study. Lack of difference in ultimate chronic
parenchymal scarring became evident only after 24 weeks while
they terminated their studies much earlier. Furthermore, the
difference in models needs to be emphasized. We deliberately
chose a mild nonprogressive infection to make any effect of iron
more evident while Glauser, Lyons, and Braude used a more
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severe and progressive infection. The self-healing nature of the
disease we produced certainly may have contributed to lack of
difference in ultimate outcome. It should be pointed out,
however, that in our study healing ultimately occurred despite
early increased numbers of bacteria, gross abscesses, and
inflammatory changes. The increased scarring in iron-treated
rats at 8, 12, and 15 weeks later might be a result of early greater
abscess formation, but it did not persist.
Miller and Phillips [8] studied the relationship between infec-
tion, renal scarring, and antimicrobial therapy. They found that
the extent of ultimate lesion was related to two factors. The first
was the rate of acquisition of bacteria and secondly, the total
number of microorganism in the kidney up to 4 days after
challenge. Early antibiotic treatment prevented or reduced
renal scarring even without reducing the number of bacteria in
the kidney. Again, this is another and different model, relying
on direct injection of bacteria into the kidney. This relationship
of early infection and subsequent scarring is complex and may
not be subject to a single overall explanation.
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